Last reviewed · How we verify
L04RD1
At a glance
| Generic name | L04RD1 |
|---|---|
| Sponsor | Celltrion |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers (PHASE1)
- A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers (PHASE1)
- A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- L04RD1 CI brief — competitive landscape report
- L04RD1 updates RSS · CI watch RSS
- Celltrion portfolio CI